1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Material disclosure
Oramed Pharmaceuticals Enters Warrant Agreement with Scilex Holding
Announce Strategic Transaction
Receives $18 Million Payment from Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Other Events
Director Resignation - Leonard Sank Steps Down from Oramed Board
Financial Results, Press Release
Declares Dividend Distribution of Common Stock Purchase Rights
FY 2025
Q3
Q2
Amended Annual Report
Q1
FY 2024
Registration of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Quarterly Report Transition
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence